- Home
- EXAS vs BILI Comparison
EXAS vs BILI Comparison
Compare EXAS & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- BILI
- Stock Information
- Founded
- EXAS 1995
- BILI 2009
- Country
- EXAS United States
- BILI China
- Employees
- EXAS N/A
- BILI N/A
- Industry
- EXAS Medical Specialities
- BILI EDP Services
- Sector
- EXAS Health Care
- BILI Technology
- Exchange
- EXAS Nasdaq
- BILI Nasdaq
- Market Cap
- EXAS 11.0B
- BILI 11.2B
- IPO Year
- EXAS N/A
- BILI 2018
- Fundamental
- Price
- EXAS $64.82
- BILI $29.43
- Analyst Decision
- EXAS Strong Buy
- BILI Buy
- Analyst Count
- EXAS 21
- BILI 7
- Target Price
- EXAS $69.24
- BILI $28.00
- AVG Volume (30 Days)
- EXAS 2.0M
- BILI 3.0M
- Earning Date
- EXAS 11-03-2025
- BILI 11-13-2025
- Dividend Yield
- EXAS N/A
- BILI N/A
- EPS Growth
- EXAS N/A
- BILI N/A
- EPS
- EXAS N/A
- BILI 0.07
- Revenue
- EXAS $2,939,949,000.00
- BILI $4,101,275,719.00
- Revenue This Year
- EXAS $16.68
- BILI $14.54
- Revenue Next Year
- EXAS $12.12
- BILI $8.91
- P/E Ratio
- EXAS N/A
- BILI $396.21
- Revenue Growth
- EXAS 12.55
- BILI 22.70
- 52 Week Low
- EXAS $38.81
- BILI $14.47
- 52 Week High
- EXAS $72.83
- BILI $30.92
- Technical
- Relative Strength Index (RSI)
- EXAS 81.05
- BILI 60.67
- Support Level
- EXAS $63.05
- BILI $28.29
- Resistance Level
- EXAS $62.31
- BILI $29.50
- Average True Range (ATR)
- EXAS 1.57
- BILI 1.10
- MACD
- EXAS 0.27
- BILI 0.05
- Stochastic Oscillator
- EXAS 92.60
- BILI 71.12
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About BILI Bilibili Inc.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.